Despite the importance of cell fusion for mammalian development and physiology, the factors critical for this process remain to be fully defined 1 . This lack of knowledge has severely limited our ability to reconstitute cell fusion, which is necessary to decipher the biochemical mechanisms driving plasma membrane merger. Myomaker (Tmem8c) is a muscle-specific protein required for myoblast fusion 2,3 . Expression of myomaker in fibroblasts drives their fusion with myoblasts, but not with other myomaker-fibroblasts, highlighting the requirement of additional myoblastderived factors for fusion. Here, we demonstrate that Gm7325, named myomerger, induces the fusion of myomaker-expressing fibroblasts. Cell mixing experiments reveal that while myomaker renders cells fusion-competent, myomerger induces fusogenicity. Thus, myomaker and myomerger confer fusogenic activity to normally non-fusogenic cells. Myomerger is skeletal muscle-specific and only expressed during developmental and regenerative myogenesis.
epithelial fusion failure (Eff-1) is sufficient to fuse typically non-fusing cells 4, 5 and mechanisms of 10 intracellular membrane fusion were partially revealed through reconstitution of SNAREs on 11 synthetic membranes [6] [7] [8] . Thus, discoveries of specific fusion proteins and development of 12 reconstitution systems have been historically critical to decipher multiple types of membrane 13 fusion, however these systems are lacking for mammalian cellular fusion. 14 Myoblast fusion is a highly specific process essential for muscle formation, and while 15 numerous proteins have been shown to regulate mammalian myoblast fusion [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] , myomaker is 16 the only known muscle-specific protein absolutely required for this process 2 . Expression of 17 myomaker in fibroblasts or mesenchymal stromal cells (MSCs) induces their fusion with muscle 18 cells 20, 21 . However, myomaker-fibroblasts do not fuse to each other indicating that additional 19 muscle-derived factors are required for fusion. To uncover potential factors, we compared genes 20 induced by expression of MyoD to their level of expression in 10T ½ fibroblasts. Of the top 100 21
MyoD-regulated genes not expressed in fibroblasts (Supplemental Information), we eliminated 22
genes not likely to be directly involved in fusion (transcription factors, sarcomeric and metabolic 23 genes) and focused on genes with transmembrane domains. This analysis yielded the following 24 five genes: Tmem182, Gm7325, Cdh15, Tspan33, and Tm6sf1, however Cdh15 was omitted 25 from further analysis because it is not necessary for myoblast fusion or muscle formation 22 . We 26 retrovirally expressed each gene in myomaker + GFP + fibroblasts and assayed for fusion. 27
Appropriate expression in fibroblasts was verified through quantitative reverse transcription 28 polymerase chain reaction (qRT-PCR) analysis (Extended Data Fig. 1a) . We observed mainly 29 mono-nucleated GFP + cells in all cultures except when Gm7325 was expressed where 30 widespread multi-nucleated cells were present (Fig. 1a) . Based on the ability of Gm7325 to 31 induce fusion of myomaker + fibroblasts and the observations described below we named the 32 protein myomerger. 33
Multiple Gm7325 transcripts are annotated in the University of California, Santa Cruz, 34 mouse genome. The shorter transcript contains a single exon and yields a protein with 84 amino 35 acids. In contrast, the longer transcript utilizes an upstream exon with an alternative start site 36 and results in a protein of 108 amino acids (Extended Data Fig. 2a ). The single coding exon of 37 the short transcript is conserved in other mammalian genomes, including humans, while the 38 upstream alternative exon leading to the longer transcript is not highly conserved (Extended 39 Data Fig. 2b) . For the initial screen we cloned the Gm7325 locus into a retroviral vector, allowing 40 normal splicing and expression of both short and long transcripts. Transduction of myomaker + 41 fibroblasts with either myomerger-short (S) or myomerger-long (L) induced formation of multi-42 nucleated cells, indicating both proteins are sufficient for fusion (Extended Data Fig. 2c) . 43
Additionally, myomerger and myomaker together induced fusion of 3T3 fibroblasts and MSCs 44 (Extended Data Fig. 2d ), suggesting these two genes could activate fusion in a multitude of cell 45
types. 46
Given that multi-nucleated cells could arise from fusion or endoreplication, we designed 47 a system to validate that multi-nucleated cells observed in fibroblasts expressing both 48 myomerger and myomaker were generated through fusion. We engineered two fibroblast cell 49 lines that both express myomaker, with one expressing GFP and the other expressing nuclear-50 localized TdTomato (NLS-Tom). Myomaker + GFP + and myomaker + NLS-Tom + fibroblasts were 51 infected with a myomerger retrovirus or a control empty retrovirus, mixed, and fusion was 52 assessed (Fig. 1b) . We observed cells with multiple nuclei containing both GFP and NLS-Tom 53 in fibroblasts expressing myomaker and myomerger indicating fusion (Fig. 1b) . Quantification 54 of fusion revealed approximately 20% of nuclei were contained in syncytia in cultures where 55 fibroblasts were expressing both myomaker and myomerger (Fig. 1b) . These results confirm 56 that the observed syncytial cells are formed through fusion and that expression of myomaker 57 and myomerger is sufficient to confer fusogenicity in non-fusogenic fibroblasts. 58
We also sought to determine the cell biology of fusion induced by myomaker and 59 myomerger. We mixed myomaker + myomerger + GFP + fibroblasts with NLS-Tom + fibroblasts 60 expressing myomaker or myomerger (Extended Data Fig. 3 Fig. 3 ). This heterotypic nature of fibroblast fusion are 63 consistent with our previously reported heterologous fusion system between myoblasts and 64 fibroblasts 2 . In that system, myomaker + fibroblasts that did not express myomerger fused with 65 muscle cells, which express both myomaker and myomerger. We next utilized our heterologous 66 fusion system where fibroblasts were infected with GFP and either empty, myomaker, or 67 myomerger retrovirus, and then mixed with C2C12 myoblasts (Fig. 1c) . In this assay, fusion is 68 detected through co-localization of GFP (fibroblasts) with myosin + myotubes. Compared to 69 empty-infected GFP + fibroblasts, we detected a significant increase in fusion between myosin + 70 cells with either myomaker + GFP + fibroblasts or myomerger + GFP + fibroblasts (Fig. 1c) . However, 71 quantification of myosin + GFP + cells revealed that myomerger did not drive the fusion of 72 fibroblasts with muscle cells to the levels observed with myomaker (Fig. 1c) . These data confirm 73 myomaker is required in both fusing cells for in vitro fusion, while myomerger is essential in one 74 fusing cell. 75
The only current information regarding Gm7325 is its potential expression in embryonic 76 stem (ES) cells 23 , therefore we interrogated its expression pattern more thoroughly. We 77 performed qRT-PCR on multiple tissues from postnatal (P) day 5 mice with primers to distinguish 78 the two potential mouse transcripts (Extended Data Fig. 4a) . In neonatal tissues, we detected 79 expression of both myomerger transcripts only in skeletal muscle (Fig. 2a) . Despite the evidence 80 of two myomerger transcripts, immunoblot analysis of skeletal muscle lysates from P5 mice 81 using a commercially available antibody identified a single band at approximately 12 kDa. This 82 band was absent in P28 lysates indicating that myomerger is downregulated after neonatal 83 development (Fig. 2b) . Skeletal muscle exhibits a robust ability to regenerate due to the 84 presence of muscle stem cells, also known as satellite cells 24, 25 . We analyzed expression of 85 myomerger in mdx 4cv mice, which is a mouse model of muscular dystrophy that leads to chronic 86 cycles of degeneration and regeneration 26 . Myomerger expression was detected in diaphragm 87 lysates from mdx 4cv mice, but not control diaphragms (Fig. 2c) . Finally, we analyzed expression 88 of myomerger in a model of skeletal muscle overload-induced (MOV) hypertrophy and observed 89 up-regulation (Fig. 2d) . Collectively, these data demonstrate that myomerger is expressed only 90 during development and is induced upon satellite cell activation in the adult. 91
We next sought to determine if myomerger is regulated as myoblasts differentiate. In 92 C2C12 cells, both Gm735 transcripts were significantly elevated during differentiation (Extended 93 Data Fig. 4b) . Similarly, myomerger protein levels were low in proliferating myoblasts (day 0), 94 but increased upon differentiation with expression maintained during myoblast differentiation and 95 fusion into myotubes (Fig. 2e) . The short mouse myomerger protein, but not the long form, ishighly conserved among vertebrate species (Extended Data Fig. 4c ). After transduction of 97 C2C12 cells with empty, myomerger-S, or myomerger-L we detected an increased upper band 98 in cells expressing either myomerger-S or myomerger-L that co-migrated with the 12 kDa 99 endogenous protein in the empty-infected C2C12 cells (Extended Data Fig. 4d) . A lower band 100 was identified exclusively in myomerger-S lysates suggesting that complex mRNA or post-101 translational processing results in the endogenous single 12 kDa band observed in WT C2C12 102 cells and muscle homogenates. Both myomerger proteins harbor a hydrophobic region close to 103 the N-terminus, where computational analysis of this region indicates a signal peptide or 104 transmembrane domain (Extended Data Fig. 4e ). Given that both variants were found to confer 105 fusogenicity, the significance of the predicted domains is presently unclear. To understand 106 subcellular localization, we fractionated C2C12 cells on day 2 of differentiation and identified 107 myomerger in membrane fractions containing caveolin-3, a protein known to associate with both 108 heavy and light vesicles (Fig. 2f) . Immunostaining of fibroblasts expressing myomerger-S or 109 myomerger-L shows that both proteins exhibit similar diffuse and vesicular localization (Fig. 2g) . 110
Thus, myomerger associates with membrane compartments consistent with its ability to induce 111
fusion. 112
The ability of myomerger to induce fusion of myomaker-fibroblasts, and its muscle-113 specific expression in the mouse, suggests that myomerger may play a critical role during 114 myogenesis. To begin to decipher the role of myomerger in myogenesis, we evaluated its 115 function during myoblast differentiation. We utilized CRISPR/Cas9 genome editing to disrupt 116 myomerger in C2C12 myoblasts. Two guide RNAs (gRNA) were designed to target the largest 117 exon of Gm7325, which resulted in a 166 base pair deletion thereby disrupting both mouse 118 transcripts (Extended Data Fig. 5a ). C2C12 cells were transfected with a plasmid containing 119
Cas9 with an IRES-GFP and myomerger gRNAs, or transfected with only Cas9-IRES-GFP as a 120 control. Flow cytometry of GFP + cells followed by genotyping through PCR analysis revealed 121 disruption of the myomerger locus (Extended Data Fig. 5b ). Myomerger was not detectable in 122 myomerger KO C2C12 cells confirming efficient disruption of the locus (Fig. 3a) . Control and 123 myomerger KO C2C12 cells were then analyzed for their ability to differentiate and form 124 myotubes. WT myoblasts differentiated, as indicated by myosin + cells, and fused to form multi-125 nucleated myotubes (Fig. 3b) . In contrast, myomerger KO C2C12 cells exhibited the ability to 126 differentiate but lacked fusogenic activity to form myotubes (Fig. 3b) (Fig. 3e) . 132
Interestingly, myogenic transcripts were elevated in myomerger KO cells potentially suggesting 133 a feedback mechanism by which non-fusogenic cells attempt to further differentiate (Fig. 3e) . 134
Infection of myomerger KO C2C12 cells with either myomerger-S or myomerger-L rescued the 135 fusion defect demonstrating that the phenotype in these cells is specifically due to the loss of 136 myomerger (Extended Data Fig. 5c ). Western blot analysis from these lysates shows re-137 expression of myomerger in KO cells (Extended Data Fig. 5d ). As a potential mechanism for the 138 lack of fusion in myomerger KO myocytes, we examined expression and localization of 139 myomaker. On day 2 of differentiation, myomerger KO cells exhibited normal expression and 140 localization of myomaker (Extended Data Fig. 6a ). Moreover, we did not detect widespread co-141 localization between myomaker and myomerger suggesting that myomerger does not directly 142 regulate myomaker distribution (Extended Data Fig. 6b ). These data reveal that myomerger is 143 necessary for myoblast fusion in vitro.
To examine the function of myomerger in vivo, we disrupted exon 3 using the same 145 CRISPR/Cas9 strategy described for C2C12 myoblasts. Injection of Cas9 and myomerger 146 gRNAs into blastocysts resulted in lethality of 9 of the 10 F 0 pups, suggesting that the high 147 efficiency of Cas9 lead to homozygous deletion of myomerger. The one remaining pup was 148 heterozygous for myomerger and was mated to generate Gm7325 -/-mice (Extended Data Fig.  149 7a). Sequencing the mutant PCR product from the heterozygous founder revealed the presence 150 of the same mutation as was achieved in C2C12 cells. We failed to observe any Gm7325 -/-mice 151 upon genotyping two litters at P7 suggesting that, in conjunction with the lethality detected 152 through initial generation of F 0 pups, myomerger is essential for life. Indeed, E17.5 Gm7325 -/-153 embryos exhibited minimal skeletal muscle upon gross examination (Fig. 4a) . Specifically, bones 154 of the limbs and rib cage were noticeable due to a scarcity of surrounding muscle as observed 155 in WT embryos. Myomerger KO mice also display a hunched appearance with elongated snouts, 156 hallmark characteristics in embryos with improper muscle formation (Fig. 4a) . Detection of 157 myomerger by western blot of WT and Gm7325 -/-tongues showed elimination of myomerger 158 protein in KO samples (Extended Data Fig. 7b ). E15.5 forelimb sections show that myomerger 159 KO myoblasts express myogenin indicating that specification and differentiation are activated 160 despite loss of myomerger (Fig. 4b) . Moreover, histological analysis of multiple muscle groups 161 at E15.5 revealed the presence of myosin + muscle cells and sarcomeric structures in myomerger 162 KO mice, ( Fig. 4c and Extended Data Fig. 7c ). While multi-nucleated myofibers were present in 163 WT mice, these structures were not readily detected in myomerger KO mice indicating that 164 genetic loss of myomerger renders myocytes non-fusogenic ( Fig. 4c and Extended Data Fig. 7c ). 165
Analysis of forelimbs from E17.5 WT and myomerger KO embryos confirm that myomerger KO 166 myoblasts are unable to properly fuse, although we did detect myocytes with two nuclei 167 (Extended Data Fig. 7d-f ). These results, together with our in vitro analysis, reveals thatmyomerger is required for muscle formation during mammalian development through regulation 169 of myoblast fusion. 170
In summary, we report the discovery of an additional muscle-specific factor required for 171 myoblast fusion and developmental myogenesis. While myomaker and myomerger are both 172 necessary for muscle formation, E17.5 myomerger KO embryos exhibit more myocytes 173 compared to embryos lacking myomaker suggesting that these two key myoblast fusion proteins 174 may have distinct functions. Given that myomaker and myomerger are both essential for 175 myoblast fusion, an understanding of their precise function will aid in the delineation of 176 mammalian plasma membrane fusion mechanisms. The fibroblast cell fusion system developed 177
here, through expression of myomaker and myomerger, provides a unique platform to decipher 178 fusion mechanisms. Moreover, the induction of cell fusion by two factors represents an avenue 179 for gene delivery to potentially any tissue. 180
Methods 182 183
Cell Culture 184 C2C12 cells, 10T 1/2 fibroblasts, and NIH/3T3 fibroblasts were purchased from American Type 185
Culture Collection and propagated in DMEM (Gibco) containing 10% heat-inactivated bovine 186 growth serum (BGS) and supplemented with antibiotics. C2C12 cells were differentiated by 187 switching to media containing 2% heat-inactivated horse serum (HS) and antibiotics. MSCs 188 were a gift from Jose Cancelas and described previously 27 . 189
190

Bioinformatic Analysis 191
Microarray data from the GEO DataSet GSE34907 28 was interrogated using GEO2R analysis to 192 identify 1826 genes displaying an increase greater than 1 log fold-change in MyoD-expressing 193 fibroblasts. In parallel, a transcriptional profile of 10T 1/2 fibroblasts transduced with empty virus 194 was generated using RNA-seq analysis (paired-end library layout using Illumina sequencing 195 platform) and a list of all genes with RPKM values below 1.5 compiled using Strand NGS 196 software (Ver. 2.6; Build: Mouse mm10 (UCSC) using Ensembl transcript annotations). These 197 two gene lists were then compared to generate a final tally comprised of 531 genes that were 198 both upregulated in MyoD-expressing fibroblasts and had low or no detectable expression in 199 10T 1/2 fibroblasts. Finally, the top 100 genes were interrogated for genes that contain 200 transmembrane domains and not previously studied for their role during myoblast fusion. 201
202
Animals 203
We used a dual sgRNA targeting strategy to create Gm7325 -/-mice. We selected the sgRNAs 204 according to the on-and off-target scores from the web tool CRISPOR 29 . The selected gRNAs 205 were 5'-GCAGCGATCGAAGCACCATC-3' and 5'-GAGGCCTCTCCAGAATCCGG-3' that target 206 exon 3 of Gm7325. The sgRNAs were in vitro synthesized using the MEGAshortscript T7 kit 207 (ThermoFisher) and purified by the MEGAclear Kit (ThermoFisher), as previously described 30 . 208 sgRNAs (50 ng/ul of each) were mixed with 100 ng/ul Cas9 protein (ThermoFisher) and 209 incubated at 37°C for 15 min to form a ribonucleoprotein complex. We then injected the mix into 210 the cytoplasm of one-cell-stage embryos of the C57BL/6 genetic background using a piezo-211 driven microinjection technique as described previously 30 . Injected embryos were immediately 212 transferred into the oviducal ampulla of pseudopregnant CD-1 females. Live born pups were 213 genotyped by PCR with the following primers: F: 5′-GAAGGGAGGACTCCACACCC-3' and R: 214 5'-CGCCTGGACTAACCGGCTCC-3'. The edited allele was further confirmed by Sanger 215 sequencing. One heterozygous founder was obtained and mated with WT C57Bl6 mice to 216 eventually generate KO mice. Mdx 4cv mice were purchased from Jackson Laboratory (#002378). 217
Muscle overload of the plantaris muscle was achieved through bilateral synergistic ablation of 218 soleus and gastrocnemius muscles as described by others 31 . Briefly, the soleus and 219 gastrocnemius muscles were exposed by making an incision on the posterior-lateral aspect of 220 the lower limb. The distal and proximal tendons of the soleus, lateral and medial gastrocnemius 221 were subsequently cut and carefully excised. All animal procedures were approved by Cincinnati 222 
Cloning and viral infection 236
We initially cloned a region of the Gm7325 locus, containing all genomic information for 237 expression of myomerger-short and myomerger-long, from C57Bl6 mouse genomic DNA using 238 the following primers: F: 5'-AGTGATGCTGAATCCACCGCA-3' and R: 5'-239 CCAATAACAACACACTGTCCT-3'. We cloned myomerger-short and long coding sequences 240 from cDNA of differentiating C2C12 cells using the following primers: myomerger-long F: 5'-241 ATGCCAGAAGAAAGCTGCACTG-3', myomerger-short F: 5'-242 ATGCCCGTTCCATTGCTCCCGA-3', and a common myomerger R: 5'-TCA CTT CTG GGG 243 GCC CAA TCT C-3'. Myomerger cDNA and genomic DNA was cloned into the retroviral vector 244 pBabe-X 2 using EcoRI. Myomaker and GFP retroviral plasmids have been described previously 2 . 245 NLS-TdTomato was subcloned from pQC-NLS-TdTomato (Addgene #37347) into the retroviral 246 vector pMX (Cell Biolabs). Plasmids containing cDNA for Tmem182, Tspan33, and Tm6sf1 from 247 the Mammalian Gene Collection were purchased from Open Biosystems and subcloned into 248 pBabe-X. Ten micrograms of retroviral plasmid DNA were transfected with FuGENE 6 (Roche) 249
into Platinum E cells (Cell Biolabs), which were plated 24 hours before transfection on a 10 cm 250 culture dish at a density of 3-4x10 6 cells per dish. Forty-eight hours after transfection, viral media 251 were collected, filtered through a 0.45 µm cellulose syringe filter and mixed with polybrene 252 (Sigma) at a final concentration of 6 µg/ml. Target cells were plated on 10 cm culture dishes at 
Western blot analysis 286
Cultured cells were washed two times with ice cold PBS, scraped into a conical tube, pelleted, 287 resuspended in lysis buffer (50 mM Tris-HCl, pH 6.8, 1mM EDTA, 2% SDS) and sonicated for a 288 total of 15 seconds (three 5 second pulses). Skeletal muscle tissues from mice were 289 homogenized with a bead homogenizer (TissueLyser II; Qiagen) in lysis buffer (10 mM Tris (pH 290 7.4), 1 mM EDTA, 1mM dithiothreitol, 0.5% Triton X-100, 2.1 mg/ml NaF) containing protease 291 and phosphatase inhibitor cocktails (5 μl/ml; Sigma-Aldrich). Both cells and tissue lysates were 292 centrifuged to pellet insoluble material and protein concentration was determined using Bradford 293 protein assay. Equal amounts of protein (5 μg for cells and 20 μg for tissues) were prepared with 294 loading buffer (1x Laemmli (Bio-Rad) with reducing agent (5% β-mercaptoethanol for cells and 295 100 mM DTT for tissues). Samples were heated at 37°C for 30 minutes and separated on a 20% 296 SDS-PAGE. The gels were subsequently transferred to a PVDF membrane (Millipore), blocked 297 in 5% milk in Tris-buffered saline/0.1% Tween-20 (TBS-T) and incubated with anti-sheep ESGP 298 antibody (1 mg/µl; R&D Systems) overnight at 4°C. Membranes were then washed with TBS-T 299 and incubated with Alexa-Fluor 647 donkey anti-sheep secondary antibody (1:5,000; Invitrogen).
Bands were visualized using the Odyssey® infrared detection system (LI-COR Biosciences). 301 GAPDH (1:5,000; Millipore) was used as a loading control. 302
303
Subcellular fractionation 304
C2C12 cells were harvested on day 2 of differentiation in ice cold hypotonic buffer (10 mM Tris-305
HCl pH 8, 2 mM EDTA) and lysed using a dounce homogenizer. Lysates were then centrifuged 306 at 800 x g for 5 mintues at 4°C to separate nuclei and cell debris. That supernatant was then 307 centrifuged at 5000 x g for 10 minutes to pellet mitochondria and ER. ER and heavy vesicles 308 were further pelleted through centrifugation at 17,000 x g for 10 minutes. Finally, plasma 309 membrane, light vesicles, and organelles were pelleted at 100,000 x g for 20 minutes and the 310 supernatant from this spin was collected as the cytosolic fraction. All pellets were resuspended 311 in lysis buffer (50 mM Tris-HCl, pH 6.8, 1mM EDTA, 2% SDS) at volumes equal to the 312 supernatant. 8 µl of each fraction was separated by SDS-PAGE and analyzed for presence of 313 myomerger, caveolin-3, and tubulin. Caveolin-3 antibody (BD Transduction Laboratories 314 #610421) was used at 1:6700 and tubulin (Santa Cruz #SC-8035) at 1:50. 315
316
Immunocytochemistry 317
Cultured cells were rinsed with PBS and fixed in 4% paraformaldehyde (PFA)/PBS for 15 318 minutes at room temperature. Cells were subsequently permeabilized and blocked in 0.01% 319 Triton X-100/5% donkey serum/PBS for one hour at room temperature. Primary antibody diluted 320 in permeabilization/blocking buffer was incubated overnight. Cells were then washed with PBS 321 and incubated with secondary Alexa-Fluor antibodies (1:250) for 1 hour. A myomaker antibody 322 custom antibody was generated through YenZym Antibodies LLC. Rabbits were immunized with 323 amino acids #137-152 of mouse myomaker (MKEKKGLYPDKSIYTQ) after conjugation to KLH.
We used antigen-specific affinity purified products at a concentration of 4.3 µg/mL for 325 immunostaining. Esgp (myomerger) antibody was used at a concentration of 1 µg/mL. Anti-326 mouse myosin (my32, MA5-11748, ThermoFisher Scientific) antibody was used at 1:100. 327
Hoechst 33342 solution (ThermoFisher Scientific) was used to stain nuclei. Cells were imaged 328 using Nikon A1R+ confocal on a FN1 microscope (35 mm dishes) or Nikon A1R confocal on 329
Eclipse T1 inverted microscope (Ibidi slides). 330 331
Histology and immunohistochemistry 332
For cryosections, embryos were dissected, fixed in 4% PFA/PBS overnight at 4°C, washed in 333 PBS, incubated in 30% sucrose/PBS overnight and then in 1:1 mix of optimal cutting temperature 334
(O.C.T.) formulation and 30% sucrose prior to embedding in O.C.T.. Sections were cut at 10 µm 335 and then permeabilized with 0.2% Triton X-100/PBS, blocked with 1% BSA/1% heat inactivated 336 goat serum/0.025% Tween20/PBS and incubated with primary antibody overnight. Anti-mouse 337 myosin (my32, MA5-11748, ThermoFisher Scientific) antibody was used at 1:100, whereas 338 myogenin (F5D, Developmental Hybridomas) was used at a concentration of 2.56 µg/mL. 339
Secondary goat anti-mouse IgG1-488 Alexa-Fluor antibody (Invitrogen) was incubated at a 340 dilution of 1:250 for 1 hour. Slides were mounted with VectaShield containing DAPI (Vector 341 Laboratories) and visualized using Nikon A1R confocal on Eclipse T1 inverted microscope. 342
Images were analyzed with Fiji. 343
344
Statistical analysis 345
For quantitation of cell fusion in Fig. 1b, cells with 3 or more nuclei were considered syncytial 346 cells. The number of nuclei in syncytial cells and total number of nuclei were manually counted. 347
In Fig. 1c, Data Fig. 3) , we calculated the percentage of GFP + NLS-Tom + syncytial cells. The 351 differentiation index (Fig. 3c) was calculated as the percentage of nuclei in myosin + cells, and 352 the fusion index (Fig. 3d) 
